These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8298987)

  • 41. Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats.
    Tejani-Butt SM; Paré WP; Yang J
    Brain Res; 1994 Jun; 649(1-2):27-35. PubMed ID: 7953642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [3H]Nisoxetine binding sites in the cat brain: an autoradiographic study.
    Charnay Y; Leger L; Vallet PG; Hof PR; Jouvet M; Bouras C
    Neuroscience; 1995 Nov; 69(1):259-70. PubMed ID: 8637624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced MPTP toxicity in noradrenaline transporter knockout mice.
    Rommelfanger KS; Weinshenker D; Miller GW
    J Neurochem; 2004 Dec; 91(5):1116-24. PubMed ID: 15569255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decrease in locus coeruleus [3H]idazoxan binding site density in genetically epilepsy-prone (GEPR) rats.
    Razani-Boroujerdi S; Tso-Olivas DY; Hoffman TJ; Weiss GK; Savage DD
    Brain Res; 1993 Jan; 600(2):181-6. PubMed ID: 8094641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.
    Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Thiele A; Heneka MT
    Neuroscience; 2011 Mar; 176():396-407. PubMed ID: 21129451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide.
    Ordway GA; Widdowson PS; Smith KS; Halaris A
    J Neurochem; 1994 Aug; 63(2):617-24. PubMed ID: 8035185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta.
    Nyquist-Battie C; Cochran PK; Evans VR; Hitchcock JM; Unal C
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1547-54. PubMed ID: 8897951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of long-term cigarette smoking on the human locus coeruleus.
    Klimek V; Zhu MY; Dilley G; Konick L; Overholser JC; Meltzer HY; May WL; Stockmeier CA; Ordway GA
    Arch Gen Psychiatry; 2001 Sep; 58(9):821-7. PubMed ID: 11545664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.
    Figlewicz DP; Brot MD; McCall AL; Szot P
    Brain Res; 1996 Oct; 736(1-2):54-60. PubMed ID: 8930308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and autoradiographic studies of the central noradrenergic system in dystonia musculorum mutant mice.
    Strazielle C; Ase AR; Lalonde R; Reader TA
    J Chem Neuroanat; 2002 Feb; 23(2):143-55. PubMed ID: 11841918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Norepinephrine transporter expression and function in noradrenergic cell differentiation.
    Sieber-Blum M; Ren Z
    Mol Cell Biochem; 2000 Sep; 212(1-2):61-70. PubMed ID: 11108137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.
    Elrod R; Peskind ER; DiGiacomo L; Brodkin KI; Veith RC; Raskind MA
    Am J Psychiatry; 1997 Jan; 154(1):25-30. PubMed ID: 8988954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional consequences of locus coeruleus degeneration in Alzheimer's disease.
    Weinshenker D
    Curr Alzheimer Res; 2008 Jun; 5(3):342-5. PubMed ID: 18537547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.
    Ghose S; Fujita M; Morrison P; Uhl G; Murphy DL; Mozley PD; Schou M; Halldin C; Innis R
    Synapse; 2005 May; 56(2):100-4. PubMed ID: 15729740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
    Mash DC; Ouyang Q; Qin Y; Pablo J
    J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.
    Gannon M; Wang Q
    Brain Res; 2019 Jan; 1702():12-16. PubMed ID: 29307592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
    Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
    Neurochem Int; 2010; 56(6-7):789-98. PubMed ID: 20211213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.